IHI.org - A resource from the Institute for Healthcare Improvement
Log In/Register
Contact Us
Site Map
Search
 
Header Image
Home > Topics > Chronic Conditions > Diabetes > Literature
Programs
Topics
Improvement
Leading System Improvement
Chronic Conditions
All Conditions
Asthma
Diabetes
How to Improve
Measures
Changes
Improvement Stories
Tools
Resources
Literature
FAQs
Critical Care
Developing Countries
End Stage Renal Disease
Flow
Healthcare-Associated Infections
Health Professions Education
HIV/AIDS
Last Phase of Life
Medical-Surgical Care
Office Practices
Patient-Centered Care
Patient Safety
Perinatal Care
Reducing Mortality
Reliability
Community
Workspace
Results
Products
About Us





Email this page
Print this page

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet. 2002;360(9326):7-22.

This study found that adding simvastatin to existing treatments safely produces substantial additional benefits for a wide range of high-risk patients, irrespective of their initial cholesterol concentrations.

This item has not yet been rated
Rate This Item

View article abstract
  Your Privacy | Terms of Use/Legal | © Institute for Healthcare Improvement